New hope to fight hidden virus in weakened immune systems
NCT ID NCT07379203
Summary
This study is testing if a drug called valganciclovir can safely lower the amount of cytomegalovirus (CMV) in the blood of people with advanced HIV. It will involve about 130 hospitalized adults and teens with very weak immune systems and a CMV infection. Participants will be randomly assigned to take either the real drug or a placebo pill for four weeks to see which one works better.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYTOMEGALOVIRUS (CMV) INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.